Have a personal or library account? Click to login
The prepulse inhibition deficit appearance is largely independent on the circadian cycle, body weight, and the gender of vasopressin deficient Brattleboro rat Cover

The prepulse inhibition deficit appearance is largely independent on the circadian cycle, body weight, and the gender of vasopressin deficient Brattleboro rat

Endocrine Regulations
Volume 50 (2016): Issue 1 (January 2016)
By: A Fodor,  B Klausz,  B Toth and  D Zelena  
Open Access
|Feb 2016

References

  1. Adams AL, Hudson A, Ryan CL, Doucette TA. Effects of estrous stage and time of day on prepulse inhibition in female rats. J Neurosci Methods 173, 295–298, 2008.10.1016/j.jneumeth.2008.06.014
    Search in Google Scholar
  2. Aliczki M, Fodor A, Balogh Z, Haller J, Zelena D. The effects of lactation on impulsive behavior in vasopressin-deficient Brattleboro rats. Horm Behav 66, 545–551, 2014.10.1016/j.yhbeh.2014.08.002
    Search in Google Scholar
  3. Bakharev VD, Tikhomirov SM, Papsuevich OS, Chipens GI. [Use of vasopressin the treatment of the paranoid form of schizophrenia]. Zh Nevropatol Psikhiatr Im S S Korsakova 84, 88–92, 1984.
    Search in Google Scholar
  4. Bohus B, de Wied D. The vasopressin deficient Brattleboro rats: a natural knockout model used in the search for CNS effects of vasopressin. Prog Brain Res 119, 555–573, 1998.10.1016/S0079-6123(08)61593-9
    Search in Google Scholar
  5. Brambilla F, Aguglia E, Massironi R, Maggioni M, Grillo W, Castiglioni R, Catalano M, Drago F. Neuropeptide therapies in chronic schizophrenia: TRH and vasopressin administration. Neuropsychobiology 15, 114–121, 1986.10.1159/000118253
    Search in Google Scholar
  6. Brambilla F, Bondiolotti GP, Maggioni M, Sciascia A, Grillo W, Sanna F, Latina A, Picotti GB. Vasopressin (DDAVP) therapy in chronic schizophrenia: effects on negative symptoms and memory. Neuropsychobiology 20, 113–119, 1989.10.1159/000118483
    Search in Google Scholar
  7. Caldwell HK, Lee HJ, Macbeth AH, Young WS, 3rd. Vasopressin: behavioral roles of an “original” neuropeptide. Prog Neurobiol 84, 1–24, 2008.10.1016/j.pneurobio.2007.10.007
    Search in Google Scholar
  8. Chabot CC, Taylor DH. Circadian modulation of the rat acoustic startle response. Behav Neurosci 106, 846–852, 1992.10.1037/0735-7044.106.5.846
    Search in Google Scholar
  9. Cilia J, Gartlon JE, Shilliam C, Dawson LA, Moore SH, Jones DN. Further neurochemical and behavioural investigation of Brattleboro rats as a putative model of schizophrenia. J Psychopharmacol 24, 407–419, 2010.10.1177/0269881108098787
    Search in Google Scholar
  10. da Silva TL, Ravindran AV. Contribution of sex hormones to gender differences in schizophrenia: A review. Asian J Psychiatr 18, 2–14, 2015.10.1016/j.ajp.2015.07.016
    Search in Google Scholar
  11. Decaux G, Soupart A, Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet 371, 1624–1632, 2008.10.1016/S0140-6736(08)60695-9
    Search in Google Scholar
  12. Elman I, Lukas S, Shoaf SE, Rott D, Adler C, Breier A. Effects of acute metabolic stress on the peripheral vasopressinergic system in schizophrenia. J Psychopharmacol 17, 317–323, 2003.10.1177/02698811030173014
    Search in Google Scholar
  13. Engelmann M, Landgraf R. Microdialysis administration of vasopressin into the septum improves social recognition in Brattleboro rats. Physiol Behav 55, 145–149, 1994.10.1016/0031-9384(94)90022-1
    Search in Google Scholar
  14. Feifel D, Priebe K. Vasopressin-deficient rats exhibit sensorimotor gating deficits that are reversed by subchronic haloperidol. Biol Psychiatry 50, 425–433, 2001.10.1016/S0006-3223(01)01100-3
    Search in Google Scholar
  15. Feifel D, Melendez G, Shilling PD. Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictive model for novel anti-psychotic effects. Neuropsychopharmacology 29, 731–738, 2004.10.1038/sj.npp.130037814760394
    Search in Google Scholar
  16. Feifel D, Priebe K. The effects of cross-fostering on inherent sensorimotor gating deficits exhibited by Brattleboro rats. J Gen Psychol 134, 173–182, 2007.10.3200/GENP.134.2.172-18217503693
    Search in Google Scholar
  17. Feifel D, Melendez G, Priebe K, Shilling PD. The effects of chronic administration of established and putative anti-psychotics on natural prepulse inhibition deficits in Brattleboro rats. Behav Brain Res 181, 278–286, 2007.10.1016/j.bbr.2007.04.02017559953
    Search in Google Scholar
  18. Feifel D, Shilling PD, Melendez G. Further characterization of the predictive validity of the Brattleboro rat model for antipsychotic efficacy. J Psychopharmacol 25, 836–841, 2011.10.1177/0269881110388327420971721106605
    Search in Google Scholar
  19. Fodor A, Barsvari B, Aliczki M, Balogh Z, Zelena D, Goldberg SR, Haller J. The effects of vasopressin deficiency on aggression and impulsiveness in male and female rats. Psychoneuroendocrinology 47, 141–150, 2014.10.1016/j.psyneuen.2014.05.01025001964
    Search in Google Scholar
  20. Forizs L. Treatment of mental patients with antidiuretic hormone of the posterior pituitary. Dis Nerv Syst 13, 44–47, 1952a.
    Search in Google Scholar
  21. Forizs L. The use of pitressin in the treatment of schizophrenia with deterioration. N C Med J 13, 76–80, 1952b.
    Search in Google Scholar
  22. Frankland PW, Ralph MR. Circadian modulation in the rat acoustic startle circuit. Behav Neurosci 109, 43–48, 1995.10.1037/0735-7044.109.1.43
    Search in Google Scholar
  23. Frederiksen SO, Ekman R, Gottfries CG, Widerlov E, Jonsson S. Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics. Acta Psychiatr Scand 83, 273–277, 1991.10.1111/j.1600-0447.1991.tb05539.x1709331
    Search in Google Scholar
  24. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 156, 117–154, 2001.10.1007/s002130100811
    Search in Google Scholar
  25. Goldman MB, Robertson GL, Luchins DJ, Hedeker D, Pandey GN. Psychotic exacerbations and enhanced vasopressin secretion in schizophrenic patients with hyponatremia and polydipsia. Arch Gen Psychiatry 54, 443–449, 1997.10.1001/archpsyc.1997.01830170069010
    Search in Google Scholar
  26. Golimbet V, Alfimova M, Abramova L, Kaleda V, Gritsenko I. Arginine vasopressin 1a receptor RS3 promoter microsatellites in schizophrenia: a study of the effect of the “risk” allele on clinical symptoms and facial affect recognition. Psychiatry Res 225, 739–740, 2015.10.1016/j.psychres.2014.11.043
    Search in Google Scholar
  27. Horlington M. Startle response circadian rhythm in rats: lack of correlation with motor activity. Physiol Behav 5, 49–53, 1970.10.1016/0031-9384(70)90012-0
    Search in Google Scholar
  28. Hosseini SM, Farokhnia M, Rezaei F, Gougol A, Yekehtaz H, Iranpour N, Salehi B, Tabrizi M, Tajdini M, Ghaleiha A, Akhondzadeh S. Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial. Eur Neuropsychopharmacol 24, 846–855, 2014.10.1016/j.euroneuro.2014.02.00124636461
    Search in Google Scholar
  29. Iager AC, Kirch DG, Bigelow LB, Karson CN. Treatment of schizophrenia with a vasopressin analogue. Am J Psychiatry 143, 375–377, 1986.10.1176/ajp.143.3.3753513631
    Search in Google Scholar
  30. Jiang X, Zhang ZJ, Zhang S, Gamble EH, Jia M, Ursano RJ, Li H. 5-HT2A receptor antagonism by MDL 11,939 during inescapable stress prevents subsequent exaggeration of acoustic startle response and reduced body weight in rats. J Psychopharmacol 25, 289–297, 2011.10.1177/026988110910691119889890
    Search in Google Scholar
  31. Jobst A, Dehning S, Ruf S, Notz T, Buchheim A, Henning-Fast K, Meissner D, Meyer S, Bondy B, Muller N, Zill P. Oxytocin and vasopressin levels are decreased in the plasma of male schizophrenia patients. Acta Neuropsychiatr 26, 347–355, 2014.10.1017/neu.2014.2025288094
    Search in Google Scholar
  32. Kohl S, Heekeren K, Klosterkotter J, Kuhn J. Prepulse inhibition in psychiatric disorders--apart from schizophrenia. J Psychiatr Res 47, 445–452, 2013.10.1016/j.jpsychires.2012.11.01823287742
    Search in Google Scholar
  33. Korsgaard S, Casey DE, Damgaard Pedersen NE, Jorgensen A, Gerlach J. Vasopressin in anergic schizophrenia. A cross-over study with lysine-8-vasopressin and placebo. Psychopharmacology (Berl) 74, 379–382, 1981.10.1007/BF004327526794086
    Search in Google Scholar
  34. Kumari V, Sharma T. Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research. Psychopharmacology (Berl) 162, 97–101, 2002.10.1007/s00213-002-1099-x
    Search in Google Scholar
  35. Le T, Xia M, Jia M, Sarkar N, Chen J, Li H, Wynn GH, Ursano RJ, Choi KH. Association between initial morphine intake and body weight change, acoustic startle reflex and drug seeking in rats. Psychopharmacology (Berl) 231, 4569–4577, 2014.10.1007/s00213-014-3606-2
    Search in Google Scholar
  36. Lehmann J, Pryce CR, Feldon J. Sex differences in the acoustic startle response and prepulse inhibition in Wistar rats. Behav Brain Res 104, 113–117, 1999.10.1016/S0166-4328(99)00058-3
    Search in Google Scholar
  37. Lehtinen EK, Ucar E, Glenthoj BY, Oranje B. Effects of melatonin on prepulse inhibition, habituation and sensitization of the human startle reflex in healthy volunteers. Psychiatry Res 216, 418–423, 2014.10.1016/j.psychres.2014.02.03024613047
    Search in Google Scholar
  38. Levin R, Heresco-Levy U, Bachner-Melman R, Israel S, Shalev I, Ebstein RP. Association between arginine vasopressin 1a receptor (AVPR1a) promoter region polymorphisms and prepulse inhibition. Psychoneuroendocrinology 34, 901–908, 2009.10.1016/j.psyneuen.2008.12.01419195791
    Search in Google Scholar
  39. Linkowski P, Geenen V, Kerkhofs M, Mendlewicz J, Legros JJ. Cerebrospinal fluid neurophysins in affective illness and in schizophrenia. Eur Arch Psychiatry Neurol Sci 234, 162–165, 1984.10.1007/BF004615556489403
    Search in Google Scholar
  40. Mai JK, Berger K, Sofroniew MV. Morphometric evaluation of neurophysin-immunoreactivity in the human brain: pronounced inter-individual variability and evidence for altered staining patterns in schizophrenia. J Hirnforsch 34, 133–154, 1993.
    Search in Google Scholar
  41. Mendrek A. Is It Important to Consider Sex and Gender in Neurocognitive Studies? Front Psychiatry 6, 83, 2015.10.3389/fpsyt.2015.00083445157726082728
    Search in Google Scholar
  42. Mlynarik M, Zelena D, Bagdy G, Makara GB, Jezova D. Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats. Horm Behav 51, 395–405, 2007.10.1016/j.yhbeh.2006.12.00717258216
    Search in Google Scholar
  43. Ohsawa H, Kishimoto T, Shimayoshi N, Matsumura K, Tahara K, Kitera K, Higashiura N, Noriyama Y, Matsumoto H, Hirai M, Ikawa G. Atrial natriuretic peptide and arginine vasopressin secretion in schizophrenic patients. Acta Psychiatr Scand 88, 130–134, 1993.10.1111/j.1600-0447.1993.tb03426.x8213206
    Search in Google Scholar
  44. Pulliam JV, Dawaghreh AM, Alema-Mensah E, Plotsky PM. Social defeat stress produces prolonged alterations in acoustic startle and body weight gain in male Long Evans rats. J Psychiatr Res 44, 106–111, 2010.10.1016/j.jpsychires.2009.05.005281334419573876
    Search in Google Scholar
  45. Reilly W, Koirala B, Devaud LL. Sex differences in acoustic startle responses and seizure thresholds between ethanol-withdrawn male and female rats. Alcohol Alcohol 44, 561–566, 2009.10.1093/alcalc/agp049
    Search in Google Scholar
  46. Robinson GE. Treatment of schizophrenia in pregnancy and postpartum. J Popul Ther Clin Pharmacol 19, e380–e386, 2012.
    Search in Google Scholar
  47. Rubin LH, Carter CS, Bishop JR, Pournajafi-Nazarloo H, Drogos LL, Hill SK, Ruocco AC, Keedy SK, Reilly JL, Keshavan MS, Pearlson GD, Tamminga CA, Gershon ES, Sweeney JA. Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders. Schizophr Bull 40, 1374–1384, 2014.10.1093/schbul/sbu027
    Search in Google Scholar
  48. Seeman MV. Clinical interventions for women with schizophrenia: pregnancy. Acta Psychiatr Scand 127, 12–22, 2013.10.1111/j.1600-0447.2012.01897.x
    Search in Google Scholar
  49. Shilling PD, Kinkead B, Murray T, Melendez G, Nemeroff CB, Feifel D. Upregulation of striatal dopamine-2 receptors in Brattleboro rats with prepulse inhibition deficits. Biol Psychiatry 60, 1278–1281, 2006.10.1016/j.biopsych.2006.03.045
    Search in Google Scholar
  50. Swerdlow NR, Geyer MA. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 24, 285–301, 1998.10.1093/oxfordjournals.schbul.a033326
    Search in Google Scholar
  51. Teltsh O, Kanyas-Sarner K, Rigbi A, Greenbaum L, Lerer B, Kohn Y. Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree. Int J Neuropsychopharmacol 15, 309–319, 2012.10.1017/S1461145711001374
    Search in Google Scholar
  52. Weiss IC, Feldon J, Domeney AM. Circadian time does not modify the prepulse inhibition response or its attenuation by apomorphine. Pharmacol Biochem Behav 64, 501–505, 1999a.10.1016/S0091-3057(99)00100-8
    Search in Google Scholar
  53. Weiss IC, Feldon J, Domeney AM. Isolation rearing-induced disruption of prepulse inhibition: further evidence for fragility of the response. Behav Pharmacol 10, 139–149, 1999b.10.1097/00008877-199903000-0000310780827
    Search in Google Scholar
  54. Yang SY, Hong CJ, Huang YH, Tsai SJ. The effects of glycine transporter I inhibitor, N-methylglycine (sarcosine), on ketamine-induced alterations in sensorimotor gating and regional brain c-Fos expression in rats. Neurosci Lett 469, 127–130, 2010.10.1016/j.neulet.2009.11.05819944746
    Search in Google Scholar
  55. Zelena D, Langnaese K, Domokos A, Pinter O, Landgraf R, Makara GB, Engelmann M. Vasopressin administration into the paraventricular nucleus normalizes plasma oxytocin and corticosterone levels in Brattleboro rats. Endocrinology 150, 2791–2798, 2009.10.1210/en.2008-100719246538
    Search in Google Scholar
DOI: https://doi.org/10.1515/enr-2016-0004 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Journal RSS Feed
Language: English
Page range: 16 - 23
Published on: Feb 22, 2016
Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
schizophrenia,
ketamine,
male,
female,
lactation,
acoustic startle response
Related subjects:
Life sciences,
Molecular biology,
Neurobiology,
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Internal medicine,
Endocrinology, diabetology

© 2016 A Fodor, B Klausz, B Toth, D Zelena, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 50 (2016): Issue 1 (January 2016)Next article